About MindFrame
MindFrame is a Healthcare company based in Irvine (United States) founded in 2007, and was acquired by Covidien in July 2012. Medical devices for ischemic stroke treatment are developed. MindFrame has raised $15.59 million across 3 funding rounds from investors including Covidien. The company has 6 employees. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is MINDFRAME, INC. Its competitors include Cardival Medical, Saranas and Aziyo Biologics; 3 of its 3 listed competitors have raised funding.
Company details
MindFrame was founded in 2007 and is based in Irvine, United States. Focus is placed on the medical device sector, where innovations for ischemic stroke treatment are developed. Operations involve the design and production of specialized devices aimed at clinical applications. Activities are centered in the healthcare industry, with emphasis on neurological interventions. Geographic presence is maintained in the United States, supporting research and development efforts.
- Headquarters Irvine, United States
- Employees 6
- Stage Acquired
- SectorsHealthcare
- Website mindframeinc.com
- Social LinkedIn
- Acquired by Covidien (Jul 2012)
- Legal Name Mindframe, Inc.
Funding Insights of MindFrame
MindFrame has successfully raised a total of $15.59M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $6.5 million completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.59M
- Total Rounds 3
- Last Round Series C — $6.5M
- First Round $7.09M
(Dec 2010)
All 3 funding rounds of MindFrame with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2012 | $6.5M | Series C | – | – | – |
| Jan 2012 | $2M | Series B | – | – | – |
| Dec 2010 | $7.09M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in MindFrame
MindFrame has secured backing from 1 investor. Prominent investors backing the company include Covidien.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical devices for minimally invasive therapies are provided globally. | 2007 | covidien.com | Dublin, Ireland |
Investor details for MindFrame
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of MindFrame
4 dated milestones of MindFrame across 5 years, from founding to its latest funding, stage changes and deals.
- Founded MindFrame is founded.
- Funding First funding round of $7.1M.
- Funding Latest funding round, Series C, of $6.5M.
- Exit Acquired by Covidien.
Competitors of MindFrame
MindFrame has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Saranas and Aziyo Biologics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| saranas.com | 2011 | Houston, United States | $29.46M | A device is developed for detecting internal bleeding during catheterization. | ||
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. |
Detailed competitors of MindFrame
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as MindFrame (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mindframe
Complete news archive for MindFrame
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MindFrame
MindFrame was founded in 2007 and raised its 1st funding round 3 years after it was founded.
MindFrame is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
MindFrame is a funded company, having raised a total of $15.59M across 3 funding rounds to date. The company's 1st funding round was a Series B of $7.09M, raised on Dec 2010.
MindFrame has 6 employees.
MindFrame was founded in 2007 and is based in Irvine, United States. Focus is placed on the medical device sector, where innovations for ischemic stroke treatment are developed. Operations involve the design and production of specialized devices aimed at clinical applications. Activities are centered in the healthcare industry, with emphasis on neurological interventions. Geographic presence is maintained in the United States, supporting research and development efforts.
MindFrame's top competitors include Cardival Medical, Aziyo Biologics and Saranas.
MindFrame has 1 investor. Key investors include Covidien.
MindFrame operates through Mindframe, Inc..
Yes. MindFrame was acquired by Covidien in July 2012.